The impact of pain on daily activities in patients with idiopathic inflammatory myopathies: Report from the OMERACT myositis working group

Further Publications Rheumatology

Construct validity of PROMIS pain interference, fatigue, and physical function as patient-reported outcomes in adults with idiopathic inflammatory myopathies: An international study from the OMERACT myositis working group

Semin Arthritis Rheum

Romich E, Saygin D, DiRenzo D, Mecoli CA, de Groot I, Lodin K, Regardt M, Sarver C, Kim JY, Park JK, Beer K, Needham M, Alexanderson H, Christopher-Stine L, de Visser M, Raaphorst J, OMERACT Myositis Working Group

doi: 10.1016/j.semarthrit.2024.152534

Autoimmune Disease

Disease activity in patients with idiopathic inflammatory myopathy according to time since diagnosis and positivity to antisynthetase autoantibodies: data from the Myo-Spain registry

Arthritis Res Ther

Cobo-Ibáñez T, Castellví I, Pros A, Domínguez-Álvaro M, Nuño-Nuño L, Martínez-Barrio J, Jovaní V, Romero-Bueno F, Ruiz-Lucea E, Tomero E, Trallero-Araguás E, Narváez J, Camins-Fàbregas J, Ruiz-Román A, Loarce-Martos J, Holgado-Pérez S, Flores-Rodríguez VM, Sivera F, Merino-Argumanez C, Juan-Mas A, Altabás-González I, Martín-López M, Belzunegui-Otano JM, Carrasco-Cubero C, Freire-González M, Rúa-Figueroa I, Lozano-Rivas N, Suarez-Cuba JD, Martínez O, Ortega-Castro R, Alcocer P, Gómez-Gómez A, Sánchez-Pernaute O, Tandaipan JL, Carrión-Barberà I, Plasencia-Rodríguez C, Ibarguengoitia-Barrena O, Vidal-Montal P, Ortiz-Santamaria V, Garrido-Puñal N, Riveros A, Delgado-Frías E, López-Gómez JM, Barbadillo C, Pego-Reigosa JM, Joven-Ibáñez BE, Valero-Jaimes JA, Naveda E, Turrión-Nieves AI, Seoane-Mato D, Prado-Galbarro FJ, Puche-Larrubia MÁ

doi: 10.1186/s13075-024-03471-x

Rheumatoid Arthritis

Association Between Patient-Reported Pain and Remission or Low Disease Activity in Patients with Rheumatoid Arthritis: Data from RA-BE-REAL Prospective Observational Study

Rheumatol Ther

Taylor PC, Fakhouri W, Ogwu S, Haladyj E, de la Torre I, Fautrel B, Alten R, Nash P, Feist E

doi: 10.1007/s40744-024-00732-8

Further Publications Immunology

Autoantibodies and damage in patients with idiopathic inflammatory myopathies: A longitudinal multicenter study from the MYONET international network

Semin Arthritis Rheum

Espinosa-Ortega F, Lodin K, Dastmalchi M, Vencovsky J, Diederichsen LP, Shinjo SK, Danieli MG, Selva-O'Callaghan A, de Visser M, Griger Z, Ceribelli A, Gómez-Martin D, Andersson H, Mercado MV, Chinoy H, Lilleker JB, New P, Krogh NS, Lundberg IE, Alexanderson H, MYONET Registry Study Group

doi: 10.1016/j.semarthrit.2024.152529

Rheumatoid Arthritis

Associations between loneliness, disease activity, and disease impact in inflammatory arthritis: A nationwide cross-sectional study among > 12,000 patients

Rheumatology (Oxford)

Vestergaard SB, Esbensen BA, Midtgaard J, Cromhout PF, Aadahl M, Glintborg B, de Thurah A

doi: 10.1093/rheumatology/keae471

Psoriatic Arthritis

Bimekizumab Improves Patient-Reported Outcomes and Work Productivity in Patients with Psoriatic Arthritis: 1-Year Results from Two Phase 3 Studies

J Rheumatol

Gladman DD, Mease PJ, Gossec L, Husni ME, Gottlieb AB, Ink B, Bajracharya R, Coarse J, Lyris N, Lambert J, Tillett W

doi: 10.3899/jrheum.2024-0923

Psoriatic Arthritis

Association of achieving clinical disease control criteria and patient-reported outcomes in bimekizumab-treated patients with active psoriatic arthritis: results from two phase III studies

Ther Adv Musculoskelet Dis

Kristensen LE, Tillett W, Nash P, Coates LC, Mease PJ, Ogdie A, Gisondi P, Ink B, Prickett AR, Bajracharya R, Taieb V, Lyris N, Lambert J, Walsh JA

doi: 10.1177/1759720X241288071

Further Publications Immunology

The impact of multimorbidity on QoL in inflammatory myopathies: COVAD cluster analysis

Rheumatology (Oxford)

Fornaro M, Venerito V, Pellico MR, Iannone F, Joshi M, Chen YM, Tan AL, Saha S, Chatterjee T, Agarwal V, Shinjo SK, Hoff LS, Kadam E, Ziade N, Velikova T, Hasan ATMT, Shumnalieva R, Milchert M, Tan CL, Edgar Gracia-Ramos A, Cavagna L, Vaidya B, Kuwana M, Sazliyana Shaharir S, Knitza J, Makol A, Zamora Tehozol EA, Rojas Serrano J, Halabi H, Dey D, Toro Gutierrez CE, Akawatcharangura Goo P, Caballero Uribe CV, Distler O, Katchamart W, Day J, Parodis I, Nikiphorou E, Chinoy H, Agarwal V, Gupta L, CoVAD Study group

doi: 10.1093/rheumatology/keae520

Atopic Dermatitis

Dupilumab provides sustained effectiveness on patient-reported outcomes and favorable safety in patients with moderate-to-severe atopic dermatitis: up to 5-year results from the daily practice BioDay Registry

J Am Acad Dermatol

Zhang J, Boesjes CM, Loman L, Kamphuis E, Romeijn MLE, Spekhorst LS, Haeck I, van der Gang LF, Dekkers CC, van der Rijst LP, Oosting AJ, van Lumig P, van Lynden-van Nes AMT, Tupker RA, Nijssen A, Flinterman A, Politiek K, Touwslager WRH, Christoffers WA, Stewart SM, Kamsteeg M, de Graaf M, de Bruin-Weller MS, Schuttelaar MA

doi: 10.1016/j.jaad.2024.04.026

Related content